Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

View:
Post by SleepyHoward on Aug 13, 2024 11:54am

Update

We will see an update soon said howard
Comment by MirrorWorldMan on Aug 13, 2024 12:50pm
Updates never turn out well.  We need announcements..preferably financial. 
Comment by Pandora on Aug 13, 2024 2:53pm
Well at least we have some volume happening today. Not so much on price but one out of two is better than what we have been getting. Over one million traded. When was the last day we did that?
Comment by Pareto8020 on Aug 13, 2024 3:14pm
Capitulation creates volume.
Comment by doonery on Aug 16, 2024 12:58pm
howard ???????????ya right,,,good luck,,
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities